Abstract

The pathogenesis and therapeutics of depression are linked to the operation of the circadian system. Here, we studied the chronopharmacological action of a tricyclic antidepressant, imipramine. Male adult Wistar–Hannover rats were administered imipramine acutely or chronically in the morning or in the evening. The antidepressant action of imipramine was analyzed using the forced swim test (FST). A single dose of imipramine (30 mg/kg) in the morning, but not in the evening, reduced immobility and increased climbing in the FST. The plasma concentrations of imipramine and its metabolite, desipramine, were slightly higher in the morning than in the evening, which might explain the dosing time-dependent action of imipramine. Next, we analyzed the effect of chronic imipramine treatment. Rats received imipramine in the morning or in the evening for 2 weeks. The morning treatment resulted in larger effects in the FST than the evening treatment, and was effective at a dose that was ineffective when administered acutely. The levels of brain α-adrenergic receptors tended to decrease after chronic imipramine treatment. Imipramine might interact with noradrenergic neurons, and this interaction might chronically alter receptor expression. This alteration seemed greater in the morning than in the evening, which might explain the dosing time-dependent action of imipramine.

Highlights

  • The pharmacological action of many substances is dependent on the circadian system, and a drug’s dosing time can affect both its therapeutic and toxic effects [1,2,3,4,5]

  • We aimed to develop a chronic animal model to analyze the ­chronopharmacological action of the antidepressant imipramine and to reveal the biochemical alterations that contribute to the chronopharmacological action of this antidepressant in this model

  • Imipramine was administered at ZT1

Read more

Summary

Introduction

The pharmacological action of many substances is dependent on the circadian system, and a drug’s dosing time can affect both its therapeutic and toxic effects [1,2,3,4,5]. Wehr et al reported that the circadian phase was advanced and desynchronized with the sleep-wake cycle in patients with ­depression, and that phase advance of the sleep-wake cycle exerted an antidepressant effect [10]. Phase entrainment by bright light in the morning is effective to improve depressive symptoms [11,12]. Chronotherapy of depression by the combination of sleep deprivation, sleep phase advance, and bright light treatment induces rapid a­ melioration in patients with depression [13]. Further research on the relationship between the c­ ircadian system and depression could lead to the development of an effective therapy for depression

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call